Mucus Relief Cough And Congestion Dm Tablet
NDC Package 54738-985-30
Package Information
Mucus Relief Cough And Congestion Dm (guaifenesin and dextromethorphan hbr) tablets is take with a full glass of wateradults and children 12 years of age and over: 1 tablet every 4 hours. This formulation utilizes a tablet delivery system. Marketed by Richmond Pharmaceuticals, Inc, this product is identified by NDC 54738-985 and is authorized under FDA application part341.
Identification & Billing
- RxCUI: 1147685 - dextromethorphan HBr 20 MG / guaiFENesin 400 MG Oral Tablet
- RxCUI: 1147685 - dextromethorphan hydrobromide 20 MG / guaifenesin 400 MG Oral Tablet
- RxCUI: 1147685 - guaifenesin 400 MG / dextromethorphan HBr 20 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54738 - Richmond Pharmaceuticals, Inc
- 54738-985 - Mucus Relief Cough And Congestion Dm
- 54738-985-30 - 30 TABLET in 1 BOTTLE
- 54738-985 - Mucus Relief Cough And Congestion Dm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54738-985). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54738-985-30 identifies a specific commercial package of 30 tablet in 1 bottle of Mucus Relief Cough And Congestion Dm, a human over the counter drug labeled by Richmond Pharmaceuticals, Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Richmond Pharmaceuticals, Inc on April 01, 2016. The current certification is valid through December 31, 2026.
How is this Richmond Pharmaceuticals, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54738098530. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.